this is just the beginning folks, co. should be valued around $500mm = $13.00 and even then I would hold for everything they have going on... the person on their Special Advisory Board is a rockstar - bascially founded Amgen and their also working with Asagawa head of NIID WHO who loves Ampligen and is working with it right now... safe profile, let along all the...
CHECK Ampligen has been used in humans for years for CFS - very similar to Long Haul Covid CHECK - Industry renown thought leader who is Director of the WHO has been working on Ampligen through Japan NIID CHECK - Roswell and other top cancer researchers have been ramping up testing of Ampligen CHECK - company has about $1.40 in net cash and restructured in...
touch the resistance and have the potential to rise.
$AIM might be looking at a potential long if MACD can cross up on the daily and volume can get in running up to earnings next Monday. Looking for exit before then. Keep in mind this is strictly opinion and not investment advice.
Despite having a history of running up exponentially -- and leaving "bagholders" in it's wake; the past couple of months have been relatively quiet. And look where price is now. I like stocks that creep up in price because they're kind of predictable (until they're not). AIM is one news story away from blowing out of that triangle. Any day now, AIM.
AIM ImmunoTech, Inc. operates as a biopharmaceutical company, which engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based disorders. Its products include Alferon N Injection and Ampligen. The Alferon N Injection is a purified, natural source, glycosylated,...
AIM is one of the stocks that have underwhelmed me in performance lately. However given current resistance wedges, I think as an entry point right now it would seem low to mid risk. I believe going in as a long hold, you can expect some positive retracement, and quite possibly a $3.15 price target by end of August. That being said, pursue at your own risk. As...
Please note: I'm just sharing my view. its not a recommendation for buying or selling.
Aim ready to boogie soon. Not financial advice Not a recommendation to buy this stock
Hello, What is AIM? AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers and immune-deficiency disorders in the United States. The company's products include Alferon N Injection, an injectable formulation of natural alpha interferon to treat a category of genital warts, a...
First off, please don't take anything I say seriously or as financial advice. As always, this is on an opinion based basis. That being said at a buy entry now, than sell good till canceled order at $3.85, I think something like this can actually be reached quite soon. AIM started having some strong support, and you can start seeing accumulation growth, and likely...